ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1400

Risk of Venous Thromboembolic Events in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies

Michelle Avina1, Sally Choi2, Sharan Rai3, Hyon K. Choi4 and Mary De Vera3,5, 1Faculty of Sciences, Arthritis Research Centre of Canada/University of British Columbia, Richmond, BC, Canada, 2Arthritis Research Centre of Canada/University of British Columbia, Richmond, BC, Canada, 3Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Boston University School of Medicine, Boston, MA, 5Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, meta-analysis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects (ACR): Comorbidities, Treatment Outcomes and Mortality

Session Type: Abstract Submissions (ACR)

Background/Purpose: Venous thromboembolism (VTE), which includes both deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common vascular event after myocardial infarction and stroke. Several studies have investigated the risk of VTE among patients with rheumatoid arthritis (RA), a chronic and disabling disease associated with systemic inflammation. Our objective was to perform a meta-analysis of studies evaluating the risk of DVT and PE in patients with RA.

Methods: We systematically searched MEDLINE (1946–2013) and EMBASE (1974–2013) databases for studies that reported the risk of VTE in patients with RA. Our search strategy employed Medical Subject Headings (MeSH terms) together with keywords for unindexed concepts relating to the themes of RA and VTE. Eligibility criteria were: 1) original data from cohort or case-control studies; 2) pre-specified RA; 3) clearly defined VTE outcomes; 4) relative risk (RR), odds ratio (OR), or hazard ratio (HR), and corresponding 95% confidence intervals (CI); 5) sex- and age-matched comparison group; and 6) English language. We calculated weight-pooled summary estimates of RRs for VTE outcomes using the random effects model. The robustness of the results was evaluated using a jack-knife sensitivity analysis (i.e., removal of a single study from the baseline group of studies). All analyses were done using HePIMA software.

Results: Our search strategy yielded 86 articles, and we identified an additional 2 citations through a hand-search of relevant bibliographies. After applying the eligibility criteria, we identified 8 studies with a total of 479,452 RA patients for inclusion in the meta-analysis. We identified 7 cohort studies (of which one reported results for three separate cohorts) and 1 case-control study. Overall, pooled estimates for VTE, DVT and PE were significantly increased (Table 1 and Figure 1). The estimates remained statistically significant in the jack-knife sensitivity analysis with the point estimates ranging from 1.58 to 1.72 and the corresponding 95% CIs >1 in all cases except for DVT.

 

Conclusion: The risk of new VTE events is increased in RA patients compared to age- and sex-matched controls. However, there exist a paucity of data on the risk of PE and DVT. These findings support increased vigilance of VTE complications and potential risk-factor intervention among RA patients.

 

Table 1. Pooled estimates on the risk of VTE events in Rheumatoid Arthritis

Events

No. of Studies

Pooled RR (95% CI)

VTE

8

1.64 (1.42, 1.89)

DVT

3

2.06 (1.14, 3.74)

PE

4

1.92 (1.85, 1.99)

 


Disclosure:

M. Avina,
None;

S. Choi,
None;

S. Rai,
None;

H. K. Choi,
None;

M. De Vera,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-venous-thromboembolic-events-in-patients-with-rheumatoid-arthritis-a-meta-analysis-of-observational-studies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology